Burger Menu

Site built by UNOMENA

Site built by UNOMENA

jkfeijeijerijerijre.png
Oviva offers an evidence-based digital solution to stop the progression of, and reverse Type 2 diabetes and obesity-related conditions. Globally, an average of one in eleven people has been diagnosed with diabetes – nearly double the proportion in 1980. In Europe, 50% of the population is overweight and at higher risk of developing Type 2 diabetes. Patients receive tailored nutrition advice and personalized coaching via their phone. Oviva’s technology-supported treatment has consistently demonstrated higher patient uptake, retention and outcomes at lower costs compared to face-to-face therapy. Oviva has treated 90,000 patients to-date across the UK, Germany, France, Switzerland and the UAE, consistently doubling each year for the last 3 years.

Lucy Jones, Clinical Director of Oviva commented: “Behavior change is the safest and most cost-effective way of preventing and managing diet related health conditions including Type 2 diabetes. Our technology, empowers patients to take a leading role in managing their health, improves compliance and outcomes.”

 The technology incorporated in Oviva's treatment strengthens the relationship between patients and professional care providers, improves patient access and reduces costs. The technology allows patients to self-record their food intake, weight, activity and symptoms, educate themselves about their disease and healthy behaviors, and communicate with other patients and their care provider. This ensures patients receive personalized support without the hassle of face-to-face appointments.

About the founders/CEO:

Oviva was founded in 2014 by an interdisciplinary team from medicine and technology who saw the challenges patients experienced accessing tailored and effective treatment as mandated by national guidelines.

Kai Eberhardt started taking an interest in healthcare when he was diagnosed with cancer, while he was pursuing his degree in physics. Luckily, he was treated successfully and thereafter has led a healthy life. After graduating from ETH Zurich with a PhD in physical chemistry, Kai worked at McKinsey, where he became associate principal.

Manuel Baumann graduated from Eidgenössische Technische Hochschule Zürich with a Master of Science in Information Technology and Electrical Engineering, before becoming a software engineer at Ompeg, followed by Hirschfactor. He then became an ICT Consultant at Accenture before founding Oviva. 

< Back Home